The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

Tirzepatide Could Replace Daily Hormone Shots for Rare Genetic Fat Disorder | Image Credit: Rutgers University
Tirzepatide Could Replace Daily Hormone Shots for Rare Genetic Fat Disorder

February 2nd 2025

Once-weekly tirzepatide may be an alternative to daily hormone shots in patients with congenital generalized lipodystrophy.

The HCPFive: Top News for Healthcare Providers from the Week of 1/26
The HCPFive: Top News for Healthcare Providers from the Week of 1/26

February 1st 2025

FDA News Month in Review: January 2025 | Image Credit: HCPLive
FDA News Month in Review: January 2025

January 31st 2025

FDA black and white logo | Credit: US Food and Drug Administration
FDA Approves Semaglutide (Ozempic) for Type 2 Diabetes, Chronic Kidney Disease

January 28th 2025

Enobosarm Protects Lean Mass in Topline Phase 2b Trial Results | Image Credit: Weill Cornell Medicine
Enobosarm Protects Lean Mass in Topline Phase 2b Trial Results

January 27th 2025

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.